Zobrazeno 1 - 10
of 685
pro vyhledávání: '"D. Gabrielli"'
Autor:
V. Quagliariello, M. L. Canale, I. Bisceglia, M. Iovine, A. Paccone, C. Maurea, M. Scherillo, A. Merola, V. Giordano, G. Palma, A. Luciano, F. Bruzzese, F. Zito Marino, M. Montella, R. Franco, M. Berretta, D. Gabrielli, G. Gallucci, N. Maurea
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundAnthracycline-mediated adverse cardiovascular events are among the leading causes of morbidity and mortality in patients with cancer. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) exert multiple cardiometabolic benefits in patients wit
Externí odkaz:
https://doaj.org/article/4ac4e155429d46e6862977792ad67451
Autor:
V. Quagliariello, M. Passariello, I. Bisceglia, A. Paccone, A. Inno, C. Maurea, R. Rapuano Lembo, L. Manna, M. Iovine, M. L. Canale, M. Scherillo, P. A. Ascierto, D. Gabrielli, C. De Lorenzo, N. Maurea
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundImmune checkpoint blockade in monotherapy or combinatorial regimens with chemotherapy or radiotherapy have become an integral part of oncology in recent years. Monoclonal antibodies against CTLA-4 or PD-1 or PDL-1 are the most studied ICIs
Externí odkaz:
https://doaj.org/article/c7cf13326e4540e69be594a83633eb43
Autor:
L. Gozzo, A. Di Lenarda, F. Mammarella, P. P. Olimpieri, A. Cirilli, M. Cuomo, M. M. Gulizia, F. Colivicchi, G. Murri, S. K. Kunutsor, D. Gabrielli, F. Trotta
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract This study aims to provide real-world data about starting-dose of NOACs and dose-adjustment in patients with atrial fibrillation (AF). In fact, even if new oral anticoagulation agents (NOACs) have a predictable effect without need for regula
Externí odkaz:
https://doaj.org/article/86c0f1aca2f745b8b6306e2397cbbc26
Autor:
P.P. Olimpieri, A. Di Lenarda, F. Mammarella, L. Gozzo, A. Cirilli, M. Cuomo, M.M. Gulizia, F. Colivicchi, G. Murri, D. Gabrielli, F. Trotta
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 26, Iss , Pp - (2020)
Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with an increased risk of stroke and thromboembolism. Anticoagulation with Vitamin K antagonists (VKAs) or with novel oral anti-coagulants (NOACs) represents the co
Externí odkaz:
https://doaj.org/article/974bab5da1d24842a57d83fc0216350c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Heart Journal Supplements. 25:D34-D35
Background Myocarditis is an inflammatory disease of myocardium, with a wide range of clinical presentation. Myocarditis may mimic acute coronary syndrome (ACS), but it is also possible an overlap between these two different syndromes, as we consider
Autor:
P Ameri, M Alings, F Colivicchi, R Collins, L De Luca, M Di Nisio, G Fabbri, D Gabrielli, S Janssens, A P Maggioni, I Parrini, F J Pinto, F M Turazza, J L Zamorano, M M Gulizia
Publikováno v:
European Heart Journal. 43
Background Evidences on atrial fibrillation (AF) in patients with cancer are limited, specifically with respect to antithrombotic therapy. Methods BLITZ-AF Cancer is a prospective, non-interventional study of the epidemiology and management of AF in
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Heart Journal Supplements. 25:D136-D136
A 72–year–old overweight man, with known hypertension and dyslipidaemia, had an episode of high intensity chest pain, which appeared at rest and lasted for several hours. A few days later, he underwent a cardiological examination and the electroc